The gender gap in substance use disorders (SUDs), characterized by greater prevalence in
men, is narrowing, highlighting the importance of understanding sex and gender differences …

Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

OBJECTIVE: To estimate fatal and nonfatal opioid overdose events in pregnant and
postpartum women in Massachusetts, comparing rates in individuals receiving and not …

Importance Racial and ethnic disparities persist across key health and substance use
treatment outcomes for mothers and infants. The use of medications, such as methadone or …

Importance The opioid epidemic increasingly affects pregnant women and developing
fetuses, resulting in high rates of neonatal abstinence syndrome. However, longitudinal …

Background The prevalence of opiate use among pregnant women can range from 1% to
2% to as high as 21%. Just in the United States alone, among pregnant women with hospital …

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the
opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine …

Abuse and Mental Health Services Administration (SAMHSA) released guidance to opioid
treatment programs relaxing some of the MMT restrictions that had been in place for more …

Background Pain during pregnancy is common, and its management is complex. Certain
analgesics may increase the risk for adverse fetal and pregnancy outcomes, while poorly …

Aim To test the effect of the duration of medication for opioid use disorder (MOUD) use
during pregnancy on maternal, perinatal and neonatal outcomes. Design Retrospective …